Tumors recur much faster in the third recurrence as compared to the first and second recurrences. A. Scheme for BGJ398 treatment and tumor recurrence (third recurrence). B. Timing of tumor regression and recurrence for individual Wnt1/iR1 tumors. C. Comparison of the recurrence latency between the first, the second and the third recurrences. Latency is calculated from the day of BGJ398 withdrawal to the day when the recurrent tumors reached 100 mm3 (n = 3); **p < 0.001. (TIF 21045 kb
Figure S1: (A) Dysregulation score was calculated according to Pathifier [32] for MAPK and JAK/STAT ...
Figure S2. PDGFA levels were validated to be upregulated in the tumorspheres compared with their par...
Receiver operating characteristics curve analysis for the optimal cutoff of the most tumor shrinkage...
Initial tumor size, extended BGJ398 treatment, and dimerizer injection have no significantly effect ...
Individual plots of tumor regression and recurrence in the BGJ398 and BGJ398 and lapatinib treatment...
Recurrent tumors are derived from the original transplanted tumor cells and have increased prolifera...
BGJ398 treatment in Wnt1/iR1 tumors results in rapid apoptosis of luminal cells and downregulation o...
Figure S1. Metastasis and local recurrence in sporadic breast cancer. 10-years Kaplan-Meier-estimate...
Lapatinib treatment reduces collagen expression in the tumor stroma. A. H&E of tumors from control o...
The number of S100A8-positive cells is positively correlated with the number of Gr1+CD11bhigh cells....
Figure S3: (A,B) Prediction of Kaplan Meier survival analysis in TCGA patients using data derived fr...
Figure S2. Age-adjusted breast cancer-free interval by breast cancer molecular subtypesa. a Luminal ...
Figure S1. Cross table for calculation of sensitivity, specificity, PPV, NPV and accuracy. Figure S2...
A Baseline NRG1 level in archival tumor samples by treatment group and indication. B Best percentage...
Effect on FGFR mRNA levels. (A) Quantification of FGFR mRNA expression in NCI-H716, Caco2, HCT116 an...
Figure S1: (A) Dysregulation score was calculated according to Pathifier [32] for MAPK and JAK/STAT ...
Figure S2. PDGFA levels were validated to be upregulated in the tumorspheres compared with their par...
Receiver operating characteristics curve analysis for the optimal cutoff of the most tumor shrinkage...
Initial tumor size, extended BGJ398 treatment, and dimerizer injection have no significantly effect ...
Individual plots of tumor regression and recurrence in the BGJ398 and BGJ398 and lapatinib treatment...
Recurrent tumors are derived from the original transplanted tumor cells and have increased prolifera...
BGJ398 treatment in Wnt1/iR1 tumors results in rapid apoptosis of luminal cells and downregulation o...
Figure S1. Metastasis and local recurrence in sporadic breast cancer. 10-years Kaplan-Meier-estimate...
Lapatinib treatment reduces collagen expression in the tumor stroma. A. H&E of tumors from control o...
The number of S100A8-positive cells is positively correlated with the number of Gr1+CD11bhigh cells....
Figure S3: (A,B) Prediction of Kaplan Meier survival analysis in TCGA patients using data derived fr...
Figure S2. Age-adjusted breast cancer-free interval by breast cancer molecular subtypesa. a Luminal ...
Figure S1. Cross table for calculation of sensitivity, specificity, PPV, NPV and accuracy. Figure S2...
A Baseline NRG1 level in archival tumor samples by treatment group and indication. B Best percentage...
Effect on FGFR mRNA levels. (A) Quantification of FGFR mRNA expression in NCI-H716, Caco2, HCT116 an...
Figure S1: (A) Dysregulation score was calculated according to Pathifier [32] for MAPK and JAK/STAT ...
Figure S2. PDGFA levels were validated to be upregulated in the tumorspheres compared with their par...
Receiver operating characteristics curve analysis for the optimal cutoff of the most tumor shrinkage...